ESSA Pharma Inc.
Androgen receptor modulators and methods for their use

Last updated:

Abstract:

The present invention relates to compounds of formula (I)-(VI) and/or (A)-(H-I), or any subgenera thereof, or a pharmaceutically acceptable salt, tautomer or stereoisomer. The compounds of the present disclosure are useful in modulating androgen receptor activity and for treating cancer including prostate cancer.

Status:
Grant
Type:

Utility

Filling date:

20 Apr 2020

Issue date:

13 Jul 2021